Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,179 | -13,630 | -12,610 | -5,391 | -5,812 |
| Depreciation Amortization | 295 | 1,272 | 975 | 736 | 365 |
| Accounts receivable | N/A | N/A | N/A | N/A | -5 |
| Other Working Capital | 869 | 1,359 | -637 | -578 | -241 |
| Other Operating Activity | -538 | -4,384 | 1,640 | -661 | 3,253 |
| Operating Cash Flow | $-4,553 | $-15,383 | $-10,632 | $-5,894 | $-2,440 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -22 | -14 | -14 | -5 |
| Investing Cash Flow | $N/A | $-22 | $-14 | $-14 | $-5 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 682 | 16,016 | 12,492 | 12,348 | 20 |
| Other Financing Activity | -246 | -1,664 | -1,387 | -1,243 | 0 |
| Financing Cash Flow | $436 | $14,352 | $11,105 | $11,105 | $20 |
| Beginning Cash Position | 6,532 | 7,585 | 7,585 | 7,585 | 7,585 |
| End Cash Position | 2,415 | 6,532 | 8,044 | 12,782 | 5,160 |
| Net Cash Flow | $-4,117 | $-1,053 | $459 | $5,197 | $-2,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,553 | -15,383 | -10,632 | -5,894 | -2,440 |
| Capital Expenditure | N/A | -22 | -14 | -14 | -5 |
| Free Cash Flow | -4,553 | -15,405 | -10,646 | -5,908 | -2,445 |